Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
RESEARCH TOOLSreports
Total Valuation
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has a market cap or net worth of AU$49.94B. The enterprise value is AU$54.74B.
Market CapAU$49.94B
Enterprise ValueAU$54.74B
Share Statistics
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,468,669,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,468,669,100
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.77%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)17.77%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee469.47K
Profits Per Employee102.30K
Employee Count9,980
Asset Turnover0.68
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is 27.52. Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s PEG ratio is 2.05.
PE Ratio27.52
PS Ratio5.69
PB Ratio5.78
Price to Fair Value5.78
Price to FCF21.84
Price to Operating Cash Flow20.05
PEG Ratio2.05
Income Statement
In the last 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh had revenue of 4.69B and earned 1.02B in profits. Earnings per share was 0.69.
Revenue4.69B
Gross Profit2.66B
Operating Income1.32B
Pretax Income1.26B
Net Income1.02B
EBITDA1.53B
Earnings Per Share (EPS)0.69
Cash Flow
In the last 12 months, operating cash flow was 1.65B and capital expenditures -93.19M, giving a free cash flow of 1.56B billion.
Operating Cash Flow1.65B
Free Cash Flow1.56B
Free Cash Flow per Share1.06
Dividends & Yields
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays an annual dividend of AU$0.082, resulting in a dividend yield of 0.87%
Dividend Per ShareAU$0.082
Dividend Yield0.87%
Payout Ratio5.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change12.31%
50-Day Moving Average35.51
200-Day Moving Average35.89
Relative Strength Index (RSI)59.73
Average Volume (3m)1.52M
Important Dates
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateMay 07, 2025
Financial Position
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh as a current ratio of 2.59, with Debt / Equity ratio of 15.14%
Current Ratio2.59
Quick Ratio1.69
Debt to Market Cap0.03
Net Debt to EBITDA0.42
Interest Coverage Ratio28.88
Taxes
In the past 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has paid 243.85M in taxes.
Income Tax243.85M
Effective Tax Rate0.19
Enterprise Valuation
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh EV to EBITDA ratio is 18.82, with an EV/FCF ratio of 22.34.
EV to Sales6.13
EV to EBITDA18.82
EV to Free Cash Flow22.34
EV to Operating Cash Flow20.51
Balance Sheet
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has AU$932.71M in cash and marketable securities with $1.39B in debt, giving a net cash position of -AU$92.94M billion.
Cash & Marketable SecuritiesAU$932.71M
Total Debt$1.39B
Net Cash-AU$92.94M
Net Cash Per Share-AU$0.06
Tangible Book Value Per ShareAU$1.04
Margins
Gross margin is 58.91%, with operating margin of 28.17%, and net profit margin of 21.79%.
Gross Margin58.91%
Operating Margin28.17%
Pretax Margin27.00%
Net Profit Margin21.79%
EBITDA Margin32.59%
EBIT Margin27.97%
Analyst Forecast
The average price target for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is AU$44.59, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$44.59
Price Target Upside21.33% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast10.54%
EPS Growth Forecast38.69%